The Commonwealth Department of Health invited HCA and a broad group of consumer representatives to engage in the Medicinal Cannabis consumer consultation, held in Melbourne on Thursday 18 May 2017.
Information was provided on medicinal cannabis government policy, and recent regulatory developments.
The review of clinical evidence for efficacy of medical cannabis was presented and the development of draft clinical guidelines for clinicians for the use of medicinal cannabis was discussed. The regulatory systems for patient access and patient access schemes were also discussed. The consultation provided the opportunity to raise issues, and for concerned patient groups to ask questions.
Consumers led a discussion about what information they need now and how best this should be communicated in a timely fashion.
You can find more information on Medicinal Cannabis on the Office of Drug Control website here.
HCA is exploring the opportunity of having a similar forum.